The settlement will benefit any person or entity in the United States who paid or provided reimbursement for some or all of the purchase price of branded or authorized generic EpiPens for the purpose of consumption, and not resale, by themselves, their family, insureds, plan participants, employees, or beneficiaries, at any point between Aug. 24, 2011, and Nov. 1, 2020, and did not exclude themselves from the Class during the initial notice period. You may be eligible for a potential award from the EpiPen Class Action Lawsuit!
According to the class action, the plaintiffs claiming Pfizer and Mylan plotted to maintain EpiPen’s monopoly by issuing large rebates to insurers and Medicaid plans that refused to cover competing medications. The class action was filed after the price of EpiPens rose from $100 to $600 in under 10 years. So if you are eligible, file a claim by November 12, 2021 to receive your potential award!
EpiPen Class Action Lawsuit
- Claim Form Deadline: November 12, 2021
- Who’s Eligible: The Class includes any person or entity in the United States who paid or provided reimbursement for some or all of the purchase price of branded or authorized generic EpiPens for the purpose of consumption, and not resale, by themselves, their family, insureds, plan participants, employees, or beneficiaries, at any point between Aug. 24, 2011, and Nov. 1, 2020, and did not exclude themselves from the Class during the initial notice period.
- Estimated Amount: Varies
- Proof of Purchase:
- No documentation is required to file a claim. However, the settlement administrator may ask for additional proof supporting your claim. The following are acceptable forms of documentation for the purchase information:
- Itemized receipts, cancelled checks, or credit card statements showing payment(s) for branded or generic EpiPens
- An EOB (explanation of benefits) from your insurer showing you paid for branded or generic EpiPens
- Pharmacy records showing you paid for branded or generic EpiPens
- Copies of records showing prescriptions written for branded or generic EpiPens
- No documentation is required to file a claim. However, the settlement administrator may ask for additional proof supporting your claim. The following are acceptable forms of documentation for the purchase information:
- Case Name & Number: In re EpiPen Marketing, Sales Practices, and Antitrust Litigation, Civil Action No. 2:17-md-02785-DDC-TJJ
(MDL No: 2785), in the U.S. District Court District of Kansas
(Click here to file a claim)
How To File a Claim
- Head over to the EpiPen Claim Form.
- Read over the claim form to see if you are eligible.
- Complete the claim form with your info.
- Submit your claim form to receive your potential award by November 12, 2021!
 |
 |
Bottom Line
The settlement will benefit any person or entity in the United States who paid or provided reimbursement for some or all of the purchase price of branded or authorized generic EpiPens for the purpose of consumption, and not resale, by themselves, their family, insureds, plan participants, employees, or beneficiaries, at any point between Aug. 24, 2011, and Nov. 1, 2020, and did not exclude themselves from the Class during the initial notice period. You may be eligible for a potential award from the EpiPen Class Action Lawsuit!
If you are eligible, file a claim by the deadline to receive your potential award! Don’t forget to take a look at our full list of Class Action Lawsuit Settlements! Be sure to give our list of No-Proof Class Action lawsuit to see other settlements you may qualify for.
Leave a Reply